Atlas Trials

A Phase I Study of IMC-A12 in Combination With Temsirolimus in Pediatric Patients With Recurrent or Refractory Solid Tumors

Clinical trial NCT01182883 · WITHDRAWN

Trial details

NCT number
NCT01182883
Sponsor
National Cancer Institute (NCI)
Status
WITHDRAWN
Phase
Phase 1
Study type
INTERVENTIONAL
Brain Stem NeoplasmsGliomaPinealoma
Start date
2010-07-28
Primary completion
2012-04-04
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.